Advertisement
Home »

Integration of CD4 T cells and molecular subtype predicts benefit from PD-L1 blockade in muscle-invasive bladder cancer.

Feb 26, 2024

ABOUT THE EXPERTS

  • Ge Liu

    NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

    Kaifeng Jin

    NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

    Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.

    Zhaopei Liu

    NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

    Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.

    Xiaohe Su

    NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

    Ziyue Xu

    NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

    Bingyu Li

    Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

    Jingtong Xu

    Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

    Hailong Liu

    Department of Urology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

    Yuan Chang

    Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.

    Yu Zhu

    Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.

    Le Xu

    Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

    Zewei Wang

    Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.

    Yiwei Wang

    Department of Urology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

    Weijuan Zhang

    Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement